Literature DB >> 20929577

Is distortion of the bioprosthesis ring a risk factor for early calcification?

Jose Manuel Martinez Cereijo1, Jose Rubio Alvarez, Juan Sierra Quiroga, Anxo Martinez de Alegria, Jose Manuel Suarez Peñaranda.   

Abstract

BACKGROUND: As the population ages, bioprosthesis are increasingly being used in cardiac valve replacement. Pericardial bioprosthesis combine an excellent hemodynamic performance with low thrombogenicity, but valve failure associated with calcification remains a concern with these valves. We describe distortion of the bioprosthesis ring as a risk factor for early calcification.
METHODS: A total of 510 patients over the age of 70 years underwent isolated aortic valve replacement with the Mitroflow (A12) pericardial bioprosthesis. Thirty two patients (6,2%) have undergone a second aortic valve replacement due to structural valve dysfunction resulting from valve calcification. In all patients a chest radiography and coronary angiography was performed before reoperation. A 64 Multidetector Computed Tomography (MDCT) with retrospective ECG gating study was performed in four patients to evaluate the aortic bioprosthesis.
RESULTS: Chest radiography showed in all patients an irregular bioprosthesis ring. At preoperative coronary angiography a distorted bioprosthesis ring was detected in all patients. Macroscopic findings of the explanted bioprostheses included extensive calcification in all specimens.
CONCLUSION: There was a possible relationship between early bioprosthetic calcification and radiologic distortion of the bioprosthesis ring.

Entities:  

Mesh:

Year:  2010        PMID: 20929577      PMCID: PMC2958891          DOI: 10.1186/1749-8090-5-77

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  6 in total

1.  Failure of four bovine pericardial mitral prostheses.

Authors:  Paul C Saunders; Eugene A Grossi; Rick A Esposito; Costas S Bizekis; Michael D Strong; Stephen B Colvin
Journal:  J Thorac Cardiovasc Surg       Date:  2004-01       Impact factor: 5.209

2.  Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.

Authors:  José García-Bengochea; Juan Sierra; José R González-Juanatey; José Rubio; Marino Vega; Angel L Fernández; Daniel Sánchez
Journal:  J Heart Valve Dis       Date:  2006-05

3.  Carpentier-Edwards supraannular porcine bioprosthesis in aortic position: 16-year experience.

Authors:  H Corbineau; B De La Tour; J P Verhoye; T Langanay; B Lelong; A Leguerrier
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

4.  Calcification and stress distribution in bovine pericardial heart valves.

Authors:  G M Bernacca; A C Fisher; R Wilkinson; T G Mackay; D J Wheatley
Journal:  J Biomed Mater Res       Date:  1992-07

5.  Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.

Authors:  Jose Rubio Alvarez; Juan Sierra; Marino Vega; Belen Adrio; Jose Martinez-Comendador; Francisco Gude; Jose Martinez-Cereijo; Javier Garcia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-08-13

6.  Mechanical stress: an independent determinant of early bioprosthetic calcification in humans.

Authors:  Kenneth K Liao; Xiaohuan Li; Ranjit John; Devesh M Amatya; Lyle D Joyce; Soon J Park; Richard Bianco; R Morton Bolman
Journal:  Ann Thorac Surg       Date:  2008-08       Impact factor: 4.330

  6 in total
  1 in total

1.  Undiagnosed mitroflow bioprosthesis deformation causing early structural valve deterioration.

Authors:  Marco Gennari; Gianluca Polvani; Mara Rubino; Francesco Arlati; Andrea Annoni; Marco Agrifoglio
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.